175 related articles for article (PubMed ID: 12088685)
1. Neutralizing antibodies against HIV -- back in the major leagues?
Ferrantelli F; Ruprecht RM
Curr Opin Immunol; 2002 Aug; 14(4):495-502. PubMed ID: 12088685
[TBL] [Abstract][Full Text] [Related]
2. Immunology. Close to the edge: neutralizing the HIV-1 envelope.
Nabel GJ
Science; 2005 Jun; 308(5730):1878-9. PubMed ID: 15976295
[No Abstract] [Full Text] [Related]
3. Do not underestimate the power of antibodies--lessons from adoptive transfer of antibodies against HIV.
Ferrantelli F; Rasmussen RA; Hofmann-Lehmann R; Xu W; McClure HM; Ruprecht RM
Vaccine; 2002 Dec; 20 Suppl 4():A61-5. PubMed ID: 12477430
[TBL] [Abstract][Full Text] [Related]
4. Antibodies: can they protect against HIV infection?
Mc Cann CM; Song RJ; Ruprecht RM
Curr Drug Targets Infect Disord; 2005 Jun; 5(2):95-111. PubMed ID: 15975016
[TBL] [Abstract][Full Text] [Related]
5. Passive immunization as tool to identify protective HIV-1 Env epitopes.
Kramer VG; Siddappa NB; Ruprecht RM
Curr HIV Res; 2007 Nov; 5(6):642-55. PubMed ID: 18045119
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing antibodies take a swipe at HIV in vivo.
Montefiori DC
Nat Med; 2005 Jun; 11(6):593-4. PubMed ID: 15937465
[No Abstract] [Full Text] [Related]
7. Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine.
Ferrantelli F; Kitabwalla M; Rasmussen RA; Cao C; Chou TC; Katinger H; Stiegler G; Cavacini LA; Bai Y; Cotropia J; Ugen KE; Ruprecht RM
J Infect Dis; 2004 Jan; 189(1):71-4. PubMed ID: 14702155
[TBL] [Abstract][Full Text] [Related]
8. Broadly neutralizing antibodies against HIV-1: templates for a vaccine.
van Gils MJ; Sanders RW
Virology; 2013 Jan; 435(1):46-56. PubMed ID: 23217615
[TBL] [Abstract][Full Text] [Related]
9. Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant.
Andrus L; Prince AM; Bernal I; McCormack P; Lee DH; Gorny MK; Zolla-Pazner S
J Infect Dis; 1998 Apr; 177(4):889-97. PubMed ID: 9534960
[TBL] [Abstract][Full Text] [Related]
10. The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context?
Braibant M; Barin F
Retrovirology; 2013 Oct; 10():103. PubMed ID: 24099103
[TBL] [Abstract][Full Text] [Related]
11. Defining the protective antibody response for HIV-1.
Mascola JR
Curr Mol Med; 2003 May; 3(3):209-16. PubMed ID: 12699358
[TBL] [Abstract][Full Text] [Related]
12. Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidate.
Chakrabarti BK; Ling X; Yang ZY; Montefiori DC; Panet A; Kong WP; Welcher B; Louder MK; Mascola JR; Nabel GJ
Vaccine; 2005 May; 23(26):3434-45. PubMed ID: 15837367
[TBL] [Abstract][Full Text] [Related]
13. Broadly Neutralizing Antibodies for HIV-1 Prevention.
Walsh SR; Seaman MS
Front Immunol; 2021; 12():712122. PubMed ID: 34354713
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
[TBL] [Abstract][Full Text] [Related]
15. Passive and active antibody studies in primates to inform HIV vaccines.
Hessell AJ; Malherbe DC; Haigwood NL
Expert Rev Vaccines; 2018 Feb; 17(2):127-144. PubMed ID: 29307225
[TBL] [Abstract][Full Text] [Related]
16. HIV vaccines. Viral envelope fails to deliver?
Bolognesi DP; Matthews TJ
Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
[No Abstract] [Full Text] [Related]
17. Neutralizing antibodies mechanism of neutralization and protective activity against HIV-1.
Xiao Y; Dong X; Chen YH
Immunol Res; 2002; 25(3):193-200. PubMed ID: 12018459
[TBL] [Abstract][Full Text] [Related]
18. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem.
Koff WC
Vaccine; 2012 Jun; 30(29):4310-5. PubMed ID: 22100891
[TBL] [Abstract][Full Text] [Related]
19. Role of neutralizing antibodies in protective immunity against HIV.
Srivastava IK; Ulmer JB; Barnett SW
Hum Vaccin; 2005; 1(2):45-60. PubMed ID: 17038830
[TBL] [Abstract][Full Text] [Related]
20. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
Mascola JR; Snyder SW; Weislow OS; Belay SM; Belshe RB; Schwartz DH; Clements ML; Dolin R; Graham BS; Gorse GJ; Keefer MC; McElrath MJ; Walker MC; Wagner KF; McNeil JG; McCutchan FE; Burke DS
J Infect Dis; 1996 Feb; 173(2):340-8. PubMed ID: 8568294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
